Disc Medicine Q2 EPS Estimate Reduced by Leerink Partnrs
Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Equities researchers at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Disc Medicine in a research report issued to clients and investors on Wednesday, May 7th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($1.20) […]
Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Equities researchers at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Disc Medicine in a research report issued to clients and investors on Wednesday, May 7th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($1.20) […]
